Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential.

Green, Brian

oai:pure.qub.ac.uk/portal:publications/f2bd63c2-b4a8-4b53-9a15-8b51ed5300bd

Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential.

Authors: Brian Green
Publication date: June 1, 2006
Publisher: 'Elsevier BV'
Doi: DOI:10.1016/j.peptides.2005.11.010

Abstract

Abstract is not available.

Similar works

Full text

Queen's University Research Portal

Provided original full text link

oai:pure.qub.ac.uk/portal:publications/f2bd63c2-b4a8-4b53-9a15-8b51ed5300bdLast time updated on 5/9/2013Provided by our Supporting member

This paper was published in Queen's University Research Portal.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.